Development of a dietary formulation of the SHetA2 chemoprevention drug for mice

Development of cancer chemoprevention compounds requires enhanced consideration for toxicity and route of administration because the target population is healthy. The small molecule drug, SHetA2 (NSC 726189), exhibited in vivo chemoprevention activity and lack of toxicity when administered by oral g...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Invest New Drugs
Huvudupphovsmän: Benbrook, Doris M., Janakiram, Naveena B., Chandra, Vishal, Pathuri, Gopal, Madka, Venkateshwar, Stratton, Nicole C., Masamha, Chioniso P., Farnsworth, Cassadie N., Garcia-Contreras, Lucila, Hatipoglu, Manolya Kukut, Lighfoot, Stan, Rao, Chinthalapally V.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer US 2017
Ämnen:
Preclinical Studies
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6014882/
https://ncbi.nlm.nih.gov/pubmed/29273857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-017-0550-0
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk